Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapy, Autoimmunity Reviews, vol.5, issue.7, pp.437-442, 2006. ,
DOI : 10.1016/j.autrev.2006.02.004
The role of B cells in animal models of rheumatoid arthritis, Frontiers in Bioscience, vol.12, issue.1, pp.1722-1736, 2007. ,
DOI : 10.2741/2184
B-cell: a logical target for treatment of rheumatoid arthritis, Clin Exp Rheumatol, vol.25, pp.318-328, 2007. ,
B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus, Nature Clinical Practice Rheumatology, vol.104, issue.1, pp.20-27, 2006. ,
DOI : 10.1038/ncprheum0042
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis & Rheumatism, vol.4, issue.10, pp.2741-2749, 2003. ,
DOI : 10.1002/art.11223
Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors, Arthritis & Rheumatism, vol.44, issue.2, pp.380-386, 2004. ,
DOI : 10.1002/art.20018
Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis, Science, vol.187, issue.4182, pp.1196-1198, 1975. ,
DOI : 10.1126/science.46621
Serum immunoglobulins and the risk of rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.56, issue.6, pp.351-356, 1997. ,
DOI : 10.1136/ard.56.6.351
Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.66, issue.1, pp.23-27, 2007. ,
DOI : 10.1136/ard.2006.052159
APRIL: A Tutorial on B Cell Survival, Annual Review of Immunology, vol.21, issue.1, pp.231-264, 2003. ,
DOI : 10.1146/annurev.immunol.21.120601.141152
The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007. ,
DOI : 10.1016/j.jbspin.2007.06.001
High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura, British Journal of Haematology, vol.166, issue.2, pp.309-314, 2007. ,
DOI : 10.1126/science.1061965
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome, Arthritis Research & Therapy, vol.8, issue.1, p.30, 2006. ,
DOI : 10.1186/ar1884
Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders, Journal of Clinical Oncology, vol.24, issue.6, pp.983-987, 2006. ,
DOI : 10.1200/JCO.2005.02.7938
Ability of oblique foot radiographs to detect erosions in early arthritis: Results in the ESPOIR cohort, Arthritis & Rheumatism, vol.30, issue.12, pp.1729-1734, 2008. ,
DOI : 10.1002/art.24310
URL : https://hal.archives-ouvertes.fr/hal-00728204
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production, Annals of the Rheumatic Diseases, vol.66, issue.5, pp.700-703, 2007. ,
DOI : 10.1136/ard.2006.060772
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis, Arthritis Research & Therapy, vol.8, issue.6, p.167, 2006. ,
DOI : 10.1186/ar2076
Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later, Arthritis & Rheumatism, vol.42, issue.11, pp.2485-2491, 2001. ,
DOI : 10.1002/1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S
A prediction rule for disease outcome in patients with Recent-onset undifferentiated arthritis: How to guide individual treatment decisions, Arthritis & Rheumatism, vol.52, issue.2, pp.433-440, 2007. ,
DOI : 10.1002/art.22380
Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register, Arthritis Research & Therapy, vol.8, issue.4, p.214, 2006. ,
DOI : 10.1186/ar1979
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset, Annals of the Rheumatic Diseases, vol.65, issue.4, pp.453-458, 2006. ,
DOI : 10.1136/ard.2005.041376
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP), Annals of the Rheumatic Diseases, vol.63, issue.9, pp.1090-1095, 2004. ,
DOI : 10.1136/ard.2003.014233
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains, Clin Chem, vol.48, pp.1437-1444, 2002. ,
Presence of four major haplotypes in human BCMA gene: lack of association with systemic lupus erythematosus and rheumatoid arthritis, Genes and Immunity, vol.2, issue.5, pp.276-279, 2001. ,
DOI : 10.1038/sj.gene.6363770
Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases, Arthritis & Rheumatism, vol.275, issue.6, pp.1313-1319, 2001. ,
DOI : 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels, Arthritis Research & Therapy, vol.8, issue.1, p.6, 2006. ,
DOI : 10.1186/ar1855
Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis, Arthritis & Rheumatism, vol.48, issue.4, pp.982-992, 2003. ,
DOI : 10.1002/art.10860
Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis, J Rheumatol, vol.35, pp.1256-1264, 2008. ,
Salmon M: Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin, Arthritis Research & Therapy, vol.7, issue.4, pp.784-795, 2005. ,
DOI : 10.1186/ar1733
Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI, Nature Immunology, vol.173, issue.3, pp.294-303, 2007. ,
DOI : 10.1038/414660a
TRANSFORMING GROWTH FACTOR-?? REGULATION OF IMMUNE RESPONSES, Annual Review of Immunology, vol.24, issue.1, pp.99-146, 2006. ,
DOI : 10.1146/annurev.immunol.24.021605.090737
BLyS and APRIL in rheumatoid arthritis, Journal of Clinical Investigation, vol.115, issue.11, pp.3083-3092, 2005. ,
DOI : 10.1172/JCI25265